Delivery Order SPE2DB20D1100-SPE2DB25FE0R6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $31,845.97. This firm fixed-price delivery order, which is expected to be completed by August 12, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a $1,413.12 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). This firm fixed-price contract, with an ultimate completion date of August 6, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was competitively made with no set-aside designation, and performance will occur at the contractor's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, valued at $2,954.20. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents a non-competitive set-aside. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.3 MG auto-injector (2-pack), with a ceiling value of $2,065.70 and an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of federal pharmaceutical procurement through AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $13,905.12 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Epinephrine 0.3 mg auto-injector units (two-pack configuration). This firm fixed-price delivery order is scheduled for ultimate completion on August 4, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, demonstrating...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $1,477.10 and an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle with the Defense Logistics Agency. The place of performance is...
- The Defense Logistics Agency awarded a $2,927.97 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This non-set-aside, competitively awarded contract is classified as a Delivery Order under a Firm Fixed Price arrangement, with an ultimate completion date of September 10, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $2,706.29 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector kits (two-pack). This competitively awarded, firm fixed-price contract is scheduled for completion by August 25, 2025, with performance taking place at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating the award was made through open competition. This...
- The Defense Logistics Agency awarded a $17,823.20 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of epinephrine 0.3 mg auto-injector two-packs, with completion scheduled for September 9, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) with a ceiling value of $17,126.26. This firm fixed-price delivery order, which is not set-aside restricted, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0R6Delivery Order
The Defense Logistics Agency awarded a $17,425.80 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Epinephrine 0.3 mg auto-injector kits (2-pack units). This firm fixed-price contract, with an ultimate completion date of August 15, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The delivery will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive pharmaceutical supply agreement with the DLA, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The epinephrine auto-injectors procured under this delivery order support emergency medical readiness for military and federal healthcare operations, with the product serving as a standard emergency treatment for anaphylaxis across military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.4k | 8/14/25 |